Analysen von James Quigley
| 10.02.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 09.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 06.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 03.02.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 02.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 30.01.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 27.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 22.01.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 21.01.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.01.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 16.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 15.01.26 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 12.01.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 12.01.26 | Sartorius Stedim Biotech Neutral | Goldman Sachs Group Inc. | |
| 12.01.26 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 15.12.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 11.12.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 09.12.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 02.12.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 27.11.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 26.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.11.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.10.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 20.10.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 20.10.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 07.10.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 02.10.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 26.09.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 12.09.25 | Novartis Sell | Goldman Sachs Group Inc. | |
| 05.09.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 08.08.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 29.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 24.07.25 | Merck Buy | Goldman Sachs Group Inc. | |
| 23.07.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 23.07.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 18.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 04.07.25 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.07.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 05.06.25 | Bayer Buy | Goldman Sachs Group Inc. | |